目的:探讨静脉留置针对结直肠腺癌化疗病人静脉化疗疗程中疼痛影响的效果评价。方法: 将乌海
市人民医院肿瘤科收治的60 名腺癌静脉化疗病人作为试验组( 水胶体+喜辽妥) ，按性别、年龄、分化程度为匹
配条件，从同期进行化疗的腺癌病人中随机抽取60 例为对照组单独使用喜辽妥。观察不同化疗疗程两组病人
上肢疼痛程度和静脉炎的发生率。结果:第一、二个疗程两组病人的疼痛程度有统计学意义( P＜0．05) 。第三个
疗程两组病人的疼痛程度差异无统计学意义( P＞0．05) ; 两组静脉炎发生率比较差异有统计学意义( P＜0．05) 。
结论:早期使用水胶体敷料和喜辽妥可减轻结直肠癌化疗病人的上肢疼痛程度，降低静脉炎的发生率，提高病人
的舒适度。

Objective: To explore the intravenous indwelling therapy intervention prevent colorectal
adenocarcinoma patients’intravenous chemotherapy pain during 3 chemotherapy course．Methods: 60
patients with adenocarcinoma of intravenous chemotherapy in Wuhai City People’ s Hospital oncology
treated as the test group ( hydrocolloid + Hirudoid) ，by gender，age，the degree of differentiation as
matching conditions，60 adenocarcinoma patients undergoing chemotherapy from the same period was
randomly selected as control group( Hirudoid used alone) ．To observe the degree of incidence of chemotherapy
treatment in patients with upper extremity pain and phlebitis groups．Ｒesults: The pain level of
the first and the second treatment shows significant differences( P＜0．05) ．And there was no significant
differences between two groups on the third course( P＞0．05) ．Phlebitis proportion difference was statistically
significant between two groups( P＜ 0．05) ．Conclusion: Combination using of hydrocolloid and
Hirudoid on colorectal patients at early chemotherapy stage could not only reduce pain level but also
decrease the incidence of phlebitis，improve patients’comfort．

Ｒ735．3+5

 收稿日期: 2018－03－17; 修回日期: 2018－07－05
基金项目:内蒙古自治区高等学校科学研究项目( NJZY14149)
作者简介:王诗淇( 1985－) ，女，内蒙古医科大学公共卫生学院，在读博士。
通讯作者:侯明星，主任医师，硕士研究生导师，E－mail: hmx6412@ 163．com 内蒙古医科大学附属医院，010050